DNA methylation in ATRA-treated leukemia cell lines lacking a PML-RAR chromosome translocation

Anticancer Research

Volumn 32, Issue 11, 2012, Pages 4715-4722

  Miftakhova, Regina ^a   Sandberg, Tove ^b   Hedblom, Andreas ^a   Nevzorova, Tatyana ^c   Persson, Jenny L ^a   Bredberg, Anders ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b MALMÖ UNIVERSITY   (Sweden)

^c KAZAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

ATRA; DNA methylation; Hep 2; HL 60 cells; p16; PML RAR chromosome translocation; U937

Indexed keywords

CELL DNA; HYBRID PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN P16; RESTRICTION ENDONUCLEASE; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION PROFILING; GENOME; HUMAN; HUMAN CELL; LEUKEMIA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CPG ISLANDS; DNA METHYLATION; HL-60 CELLS; HUMANS; LEUKEMIA; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRETINOIN; U937 CELLS;

EID: 84872670138     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Glasow A, Prodromou N, Xu K, von Lindern M and Zelent A: Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways. Blood 105: 341-349, 2005.
2. Fazi F, Zardo G, Gelmetti V, Travaglini L, Ciolfi A, Di Croce L, Rosa A, Bozzoni I, Grignani F, Lo-Coco F, Pelicci PG and Nervi C: Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. Blood 109: 4432-4440, 2007.
3. Petrie K, Zelent A and Waxman S: Differentiation therapy of acute myeloid leukemia: Past, present and future. Curr Opin Hematol 16: 84-91, 2009.
4. 3. Br J Haematol 112: 315-326, 2001.
5. Park SH, Jung JK, Lim JS, Tiwari I and Jang KL: Hepatitis B virus X protein overcomes all-trans retinoic acid-induced cellular senescence by down-regulating levels of p16 and p21 via DNA methylation. J Gen Virol 92: 1309-1317, 2011.
6. Cimino G, Lo-Coco F, Fenu S, Travaglini L, Finolezzi E, Mancini M, Careddu A, Fazi F, Padula F, Fiorini R, Spiriti MA, Petti MC, Venditti A, Amadori S, Mandelli F, Pelicci PG and Nervi C: Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia. Cancer Res 66: 8903-8911, 2006.
7. Kuendgen A and Gattermann N: Valproic acid for the treatment of myeloid malignancies. Cancer 110: 943-954, 2007.
8. Nowak D, Stewart D and Koeffler HP: Differentiation therapy of leukemia: three decades of development. Blood 113: 3655-3656, 2009.
9. Nouzova M, Holtan N, Oshiro MM, Isett RB, Munoz-Rodriguez JL, List AF, Narro ML, Miller SJ, Merchant NC and Futscher BW: Epigenomic changes during leukemia cell differentiation: Analysis of histone acetylation and cytosine methylation using CpG island microarrays. J Pharmacol Exp Ther 311: 968-981, 2004.
10. Stirzaker C, Song JZ, Davidson B and Clark SJ: Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res 64: 3871-3877, 2004.
11. Ushijima T: Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 5: 223-231, 2005.
12. Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA and Clark SJ: Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 38: 540-549, 2006.
13. Bredberg A and Bodmer W: Cytostatic drug treatment causes seeding of gene promoter methylation. Eur J Cancer 43: 947-954, 2007.
14. Lewin J, Schmitt AO, Adorjan P, Hildmann T and Piepenbrock C: Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics 20: 3005-3012, 2004.
15. Pogribny I, Yi P and James SJ: A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Biochem Biophys Res Commun 262: 624-628, 1999.
16. Snedecor GW and Cochran WG: Statistical Methods 6th ed. Ames Iowa: Iowa State University Press; 1967.
17. Rice KL, Hormaeche I and Licht JD: Epigenetic regulation of normal and malignant hematopoiesis. Oncogene 26: 6697-6714, 2007.
18. Hinshelwood RA, Melki JR, Huschtscha LI, Paul C, Song JZ, Stirzaker C, Reddel RR and Clark SJ: Aberrant de novo methylation of the p16 INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hum Mol Genet 18: 3098-3109, 2009.